Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2017

01-12-2017 | Letter to the Editor

Comment on 'Association between serum osteocalcin and body mass index: a systematic review and meta-analysis.'

Authors: Xiaoying Liu, Kaye E. Brock, PhD, Tara C. Brennan-Speranza, PhD

Published in: Endocrine | Issue 3/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
M. Liao, X. Guo, X. Yu, G. Pang, S. Zhang, J. Li, A. Tan, Y. Gao, X. Yang, H. Zhang, X. Qin, L. Mo, Z. Lu, C. Wu, Z. Mo, Role of Metabolic Factors in the Association Between Osteocalcin and Testosterone in Chinese Men. J. Clin. Endocrinol. Metabol. 98(8), 3463–3469 (2013). https://​doi.​org/​10.​1210/​jc.​2013-1805 CrossRef
4.
5.
6.
7.
A. Movahed, B. Larijani, I. Nabipour, M. Kalantarhormozi, K. Asadipooya, K. Vahdat, S. Akbarzadeh, M. Farrokhnia, M. Assadi, R. Amirinejad, A. Bargahi, Z. Sanjdideh, Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J. Bone Miner. Metab. 30(6), 683–691 (2012). https://​doi.​org/​10.​1007/​s00774-012-0367-z CrossRefPubMed
8.
K. Bezerra dos Santos Magalhães, M. Moreira Magalhães, E. Trovão Diniz, C. Salgado Lucena, L. Griz, F. Bandeira, Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann. Nutr. Metabol. 62(3), 183–188 (2013)CrossRef
9.
D.M. Eddy, L. Schlessinger, K. Heikes, The metabolic syndrome and cardiovascular risk: implications for clinical practice. Int. J. Obes. 32(S2), S5–S10 (2008)CrossRef
Metadata
Title
Comment on 'Association between serum osteocalcin and body mass index: a systematic review and meta-analysis.'
Authors
Xiaoying Liu
Kaye E. Brock, PhD
Tara C. Brennan-Speranza, PhD
Publication date
01-12-2017
Publisher
Springer US
Published in
Endocrine / Issue 3/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1456-5

Other articles of this Issue 3/2017

Endocrine 3/2017 Go to the issue

Research Letter

Intestinal absorption and buccal absorption of liquid levothyroxine

Original Article

Physiological serum 25-hydroxyvitamin D concentrations are associated with improved thyroid function—observations from a community-based program

Original Article

Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience

Original Article

Real-time elastography in autonomously functioning thyroid nodules: relationship with TSH levels, scintigraphy, and ultrasound patterns

Original Article

Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival

Endocrine Methods and Techniques

Imaging of diabetic bone
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits